Findings

What do systematic reviews say?

Refine by population, intervention, comparison or outcome
More filters
Evidence found and GRADE certainty

99 questions · 100 findings · 9 reviews · Musculoskeletal

No studies found 22 · 22%GRADE not reported 0 · 0%Very low 9 · 9%Low 27 · 27%Moderate 36 · 36%High 6 · 6%

Folinic acid vs placebo

Liver toxicity (incidence of transaminase elevation) · Patients receiving methotrexate for rheumatoid arthritis

Folinic acid probably leads to lower liver toxicity (incidence of transaminase elevation) compared with placebo (moderate certainty).

1 finding from 1 review

Folic or folinic acid (any) vs placebo

Stomatitis / mouth sores (incidence) · Patients receiving methotrexate for rheumatoid arthritis

Folic or folinic acid (any) showed no clear difference in stomatitis / mouth sores (incidence) compared with placebo (moderate certainty).

1 finding from 1 review

Folic or folinic acid (any) vs placebo

Liver toxicity (incidence of transaminase elevation) · Patients receiving methotrexate for rheumatoid arthritis

Folic or folinic acid (any) probably leads to lower liver toxicity (incidence of transaminase elevation) compared with placebo (moderate certainty).

1 finding from 1 review

Folic or folinic acid (any) vs placebo

Haematological disorders (neutropenia, etc) · Patients receiving methotrexate for rheumatoid arthritis

Folic or folinic acid (any) showed no clear difference in haematological disorders (neutropenia, etc) compared with placebo (low certainty).

1 finding from 1 review

Summary of findings: Folic acid vs placebo

GI side effects (ie, incidence of nausea, vomiting, abdominal pain) · Patients receiving methotrexate for rheumatoid arthritis

Folic acid showed no clear difference in GI side effects (ie, incidence of nausea, vomiting, abdominal pain) compared with placebo (moderate certainty).

1 finding from 1 review

Intervention not reported

ACR 50 American College of Rheumatology improvement criteria · patients with rheumatoid arthritis

The intervention probably leads to higher ACR 50 American College of Rheumatology improvement criteria (moderate certainty).

1 finding from 1 review

Intervention not reported

Remission3 · patients with rheumatoid arthritis
1 finding from 1 review